NCR2 and chronic myelogenous leukemia, BCR-ABL1 positive: CML patients achieving deep molecular response showed (Figure 5E) a significant reduction of the density of NKp44 at the surface of NKT-like cells (MFI: 48.1 ± 12.9 vs. 67.9 ± 16.8; p = 0.0101).